Literature DB >> 12718893

Structural basis for bile acid binding and activation of the nuclear receptor FXR.

Li-Zhi Mi1, Srikripa Devarakonda, Joel M Harp, Qing Han, Roberto Pellicciari, Timothy M Willson, Sepideh Khorasanizadeh, Fraydoon Rastinejad.   

Abstract

The nuclear receptor FXR is the sensor of physiological levels of enterohepatic bile acids, the end products of cholesterol catabolism. Here we report crystal structures of the FXR ligand binding domain in complex with coactivator peptide and two different bile acids. An unusual A/B ring juncture, a feature associated with bile acids and no other steroids, provides ligand discrimination and triggers a pi-cation switch that activates FXR. Helix 12, the activation function 2 of the receptor, adopts the agonist conformation and stabilizes coactivator peptide binding. FXR is able to interact simultaneously with two coactivator motifs, providing a mechanism for enhanced binding of coactivators through intermolecular contacts between their LXXLL sequences. These FXR complexes provide direct insights into the design of therapeutic bile acids for treatment of hyperlipidemia and cholestasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718893     DOI: 10.1016/s1097-2765(03)00112-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  73 in total

1.  Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.

Authors:  A F Hofmann
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

2.  Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitro.

Authors:  Deanna L Howarth; Lee R Hagey; Sheran H W Law; Ni Ai; Matthew D Krasowski; Sean Ekins; John T Moore; Erin M Kollitz; David E Hinton; Seth W Kullman
Journal:  Aquat Toxicol       Date:  2010-03-01       Impact factor: 4.964

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 4.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

5.  Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.

Authors:  Ruitang Deng; Dongfang Yang; Jian Yang; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2005-12-21       Impact factor: 4.030

6.  The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.

Authors:  Tamara Frankenberg; Tamir Miloh; Frank Y Chen; Meena Ananthanarayanan; An-Qiang Sun; Natarajan Balasubramaniyan; Irwin Arias; Kenneth D R Setchell; Frederick J Suchy; Benjamin L Shneider
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

7.  Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

Authors:  Liping Yang; David Broderick; Yuan Jiang; Victor Hsu; Claudia S Maier
Journal:  Biochim Biophys Acta       Date:  2014-06-18

8.  Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists.

Authors:  Carmen Festa; Claudia Finamore; Silvia Marchianò; Francesco Saverio Di Leva; Adriana Carino; Maria Chiara Monti; Federica Del Gaudio; Sara Ceccacci; Vittorio Limongelli; Angela Zampella; Stefano Fiorucci; Simona De Marino
Journal:  ACS Med Chem Lett       Date:  2019-01-10       Impact factor: 4.345

Review 9.  The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Authors:  Folkert Kuipers; Thierry Claudel; Ekkehard Sturm; Bart Staels
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

10.  Structure of the heterodimeric ecdysone receptor DNA-binding complex.

Authors:  Srikripa Devarakonda; Joel M Harp; Youngchang Kim; Andrzej Ozyhar; Fraydoon Rastinejad
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.